KI receives SEK 6.5 million in funding for COVID-19 research
Thirteen KI researchers have received funding from the Heart-Lung Foundation for their research on the new coronavirus. The grants total SEK 6.5 million, with approximately 40 per cent of the grants being distributed by the Heart-Lung Foundation (2021). The focus of the research is on the aftermath of COVID-19 where the disease has caused late complications on the heart, vessels and lungs. A total of SEK 15.7 million was distributed to 30 research projects at six different universities.
Researchers and projects that have received funding:
Charlotte Thålin at the Department of Clinical Sciences, Danderyd Hospital, for the project "Prognostic biomarkers for severe COVID-19 disease and complications".
Peter Lindholm at the Department of Physiology and Pharmacology, for the project "Can we cure long-term symptoms after COVID-19 with hyperbaric oxygen (HBO): A randomised placebo-controlled drug trial".
Malin Nygren Bonnier at the Department of Neurobiology, Health Sciences and Society, for the project "Effect of specific interventions for patients with long covid-19".